Panel discussion, 11 December 2020
Guaranteeing Access to Medicines: Reforming Trade and Investment Treaties in the COVID-19 Era
Eight months into COVID-19, what is the status of the international investment regime and access to essential medicines? The GDP Center’s Working Group on Trade and Access to Medicines will host a panel discussion on trade, the investment regime, and access to essential medicines. The event is co-sponsored by the South Centre, the intergovernmental organization of developing nations based in Switzerland.
Moderator:
- Kevin P. Gallagher – Director, Global Development Policy Center; Professor, Pardee School of Global Studies Boston University
Presenters:
- Carlos Correa – Executive Director, South Centre
- Mustaqeem de Gama – Counsellor, South Africa WTO Mission
- Mariangela Simao – Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, World Health Organization
- Yousuf Vawda – Professor & Senior Research Associate, University of Kwazulu-Natal School of Law
- Deborah Gleeson – Senior Lecturer, La Trobe University
- STARTS:
- 7:00 am EST//1:00 pm CET on Friday, Dec. 11, 2020
- ENDS:
- 08:30 am EST//2:30 pm CET on Friday, Dec. 11, 2020
- LOCATION:
- Via Zoom
This article was tagged: Access to Medicines, COVID-19, International Investment Agreements (IIAs), Investment Agreement, Investment Treaties, Reform of the IIA regime, Trade
